The VP.S ENCORE™ device is designed to have a significant impact on patients awaiting lifesaving or life-altering transplant surgeries by extending the viability of organs outside the body, and by extending the time for transport compared to traditional ice cooler technology. The primary goal in developing the VP.S ENCORE™ device include the ability to expand the donor organ pool, optimizing matching of the donor organs, and to minimize rejection.
The initial target organ for use of the VP.S ENCORE™ device is the heart. Outcome data collected to demonstrate optimal performance of the VP.S ENCORE™ device in animal studies include:
Preclinical tests demonstrate excellent preservation using animal hearts and human hearts donated for research.
In addition to having a positive impact on the lives of patients awaiting transplants, the VP.S ENCORE™ device is designed to allow surgeons and surgical centers to better schedule and manage their procedures. Moreover, should more organs become available for transplant, surgeons will ideally be able to perform more lifesaving and life-transforming surgeries.
If you are interested in receiving periodic updates, please email us at firstname.lastname@example.org